Tirzepatide vs semaglutide injection site reactions Many researchers wonder whether switching medications would eliminate injection site issues
Its important for users to monitor for symptoms of hypoglycemia (low blood sugar) and seek medical advice for any severe or persistent side effects
Although GI AEs are common across all GLP-1 RAs, differences in formulation, dosing, and dual agonism with tirzepatide can influence how well patients tolerate therapy
For multi-dose pens, removing visible larger air bubbles helps ensure accurate dosing, though small bubbles are harmless
Conversely, in a recent randomized, double-blind, placebo-controlled study involving twenty healthy volunteers, a once-weekly injection of a GLP-1R agonist, dulaglutide, for three weeks did not influence HPA axis activity, showing no significant effects on circadian rhythms of blood or salivary cortisol secretion, and the level of this hormone also was not changed after the dexamethasone suppression test in comparison with the placebo-receiving group [78]